Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor

Clinical trial NCT05009966 · UNKNOWN

Trial details

NCT number: NCT05009966
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Gastric Cancer (GC)Gastroesophageal Junction (GEJ) Cancer Pancreatic Cancer

Start date: 2021-09-16
Primary completion: 2023-12-01
Enrollment: 272

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.